Visão geral da empresa NeurogesX
Biotecnologia e farmacêuticaIndústria
NeurogesX is paving the way for treating neuropathic pain, or chronic pain caused by damaged nerves. The company's lead candidate is Qutenza (formerly known as NGX-4010), a skin patch that uses a synthetic version of capsaicin (an ingredient in hot peppers) to lessen nerve pain. NeruogesX has been developing the drug in the US and Europe for a number of pain indications, including post-herpetic neuralgia (caused by shingles), diabetic neuropathy, and neuropathic pain associated with HIV. However, the drug is furthest advanced in the US as a treatment for post-herpetic neuralgia. Other product candidates in the NeurogesX pipeline include a liquid formulation of synthetic capsaicin and an opioid pain reliever.
